Retrospective Evaluation of CroFab - Efficacy in Severe Envenomation

Inclusion Criteria

• •Must involve treatment of a human patient with CroFab between January 1, 2002 and December 31, 2004
• •The record must contain all of the following:
• •1. Clinical signs/symptoms prior to the first dose of antivenom,
• •2. Documentation of all doses of antivenom used to treat the patient,
• •3. Indication of whether or not initial control was achieved with antivenom.
• •To be included in the Efficacy Evaluable Population (EEP) in the current analysis, each record must meet the following criteria:
• •Must contain enough information to calculate a severity score based on the 7-point severity scale.
• •All records were included in the Safety Population in the current analysis.